SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-037446
Filing Date
2019-06-25
Accepted
2019-06-25 17:26:14
Documents
7
Period of Report
2019-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12093_18k.htm 8-K 60915
2 EX-2.1 a19-12093_1ex2d1.htm EX-2.1 783671
3 EX-2.2 a19-12093_1ex2d2.htm EX-2.2 42128
4 EX-2.3 a19-12093_1ex2d3.htm EX-2.3 139346
5 EX-10.1 a19-12093_1ex10d1.htm EX-10.1 718322
6 EX-99.1 a19-12093_1ex99d1.htm EX-99.1 1176683
7 GRAPHIC g120931mm09i001.jpg GRAPHIC 1940
  Complete submission text file 0001104659-19-037446.txt   2925112
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 19919436
SIC: 2834 Pharmaceutical Preparations